Streetbeat News

Stock Prices

ZOM

Zomedica's shares dropped following a report of decreased year-over-year GAAP EPS for Q1 and sales results that fell below expectations.

Portfolio Pulse from Benzinga Newsdesk

May 10, 2024 | 10:54 am

LIDR

AEye, Inc. (LIDR) shares are trading higher following the announcement of a partnership with LITEON Technology Corporation, indicating a positive market response to the new collaboration.

Portfolio Pulse from Benzinga Newsdesk

May 10, 2024 | 10:54 am

PLX

Protalix BioTherapeutics reported a Q1 2024 GAAP EPS of $(0.06), missing the $(0.02) estimate, with sales of $3.748M, a decrease from $9.588M year-over-year.

Portfolio Pulse from Benzinga Newsdesk

May 10, 2024 | 10:53 am

GELYY

MBLY

ZK

Zeekr Intelligent Technology Holding Limited (NYSE:ZK) priced its U.S. IPO at $21 per share, at the top end of its estimated range, with shares to begin trading on May 10, 2024. The offering is expected to close on May 14, 2024, potentially raising up to $507.2 million if the underwriters' over-allotment option is fully exercised. Strategic investors including Geely Automobile Holding (OTC:GELYY), Contemporary Amperex Technology, and Mobileye Global Inc (NASDAQ:MBLY) accounted for $300 million of the IPO. Despite a strong demand for Zeekr's IPO, analysts are skeptical about an imminent surge of Chinese listings in New York.

Portfolio Pulse from Shivani Kumaresan

May 10, 2024 | 10:52 am

MGNX

MacroGenics shares are trading lower following the announcement of worse-than-expected Q1 financial results.

Portfolio Pulse from Benzinga Newsdesk

May 10, 2024 | 10:48 am

DNOW

NOW Inc. (DNOW) reported Q1 2024 earnings of $0.21 per share, missing the consensus estimate of $0.23. Quarterly sales were $563 million, below the estimate of $569.150 million, marking a 3.60% decrease from the previous year.

Portfolio Pulse from Benzinga Newsdesk

May 10, 2024 | 10:47 am

RXRX

Recursion Pharmaceuticals' shares surged following the announcement of their Q1 financial results, which exceeded expectations.

Portfolio Pulse from Benzinga Newsdesk

May 10, 2024 | 10:47 am

BMBL

B of A Securities analyst Curtis Nagle upgrades Bumble (NASDAQ:BMBL) from Neutral to Buy, maintaining a $14 price target.

Portfolio Pulse from Benzinga Newsdesk

May 10, 2024 | 10:47 am

SG

Sweetgreen shares are trading higher following the announcement of better-than-expected Q1 sales results.

Portfolio Pulse from Benzinga Newsdesk

May 10, 2024 | 10:47 am

GRPN

Groupon shares surged following the announcement of their Q1 results, which exceeded market expectations.

Portfolio Pulse from Benzinga Newsdesk

May 10, 2024 | 10:46 am